EP Patent

EP2177521A1 — New 2-Amidothiadiazole Derivatives

Assigned to Almirall SA · Expires 2010-04-21 · 16y expired

What this patent protects

New 2-amidothiadiazole derivatives having the chemical structure of formula (I) or pharmaceutically acceptable salts or N-oxides thereof as agonists of S1P1 receptors.

USPTO Abstract

New 2-amidothiadiazole derivatives having the chemical structure of formula (I) or pharmaceutically acceptable salts or N-oxides thereof as agonists of S1P1 receptors.

Drugs covered by this patent

Patent Metadata

Patent number: EP2177521A1
Jurisdiction: EP
Classification: —
Expires: 2010-04-21
Drug substance claim: No
Drug product claim: No
Assignee: Almirall SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.